StockNews.com began coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note issued to investors on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Stock Performance Shares of RedHill Biopharma stock opened at $0.46 on Tuesday. RedHill Biopharma has a twelve month low of $0.26 […]

Related Keywords

Redhill Biopharma , Redhill Biopharma Company Profile , Gagnon Securities , Sabby Management , Armistice Capital , Redhill Biopharma Ltd , Free Report , Get Free Report , Hill Biopharma Ltd , Redhill Biopharma Daily ,